Understanding pulmonary hypertension: the need for an integrative metabolomics and transcriptomics approach

Abstract excerpt

Pulmonary hypertension (PH), characterised by mean pulmonary arterial pressure (mPAP) >20 mm Hg at rest, is a complex pathophysiological disorder associated with multiple clinical conditions. The high prevalence of the disease along with increased mortality and morbidity makes it a global health burden. Despite major advances in understanding the disease pathophysiology, much of the underlying complex molecular...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Liver Disease Diagnosis and Treatment
• Share to Metabolomics and Mass Spectrometry Studies
• Share to Pulmonary Hypertension Research and Treatments